ASKA Pharmaceutical Holdings CO., Ltd. (4886) Cash flow
Market cap
¥74B
P/E ratio
15.2x
Asuka Pharmaceutical Holdings operates through subsidiaries that manufacture prescription drugs, veterinary medicines, and medical devices for healthcare providers globally.
| 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Depreciation & amortization | 2,885 | 3,127 | 2,662 | 2,247 | 2,917 |
| Cash from operations | 2,842 | 3,351 | 1,486 | 2,485 | 6,303 |
| Capital expenditures | -579 | -461 | -1,320 | -2,960 | -2,549 |
| Cash from investing | 6,743 | -1,126 | 1,706 | -6,124 | -5,752 |
| Payments for dividends | -398 | -452 | -792 | -1,275 | -1,617 |
| Proceeds from issuance of term debt, net | - | - | - | 3,000 | 3,500 |
| Repayments of term debt | -2,298 | -1,423 | -3,138 | -4,680 | -1,937 |
| Cash from financing | -2,996 | -1,820 | -3,943 | -2,956 | -818 |